Document Detail


Increased tissue factor pathway inhibitor in patients with acute myocardial infarction.
MedLine Citation:
PMID:  9257877     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We examined hemostatic abnormalities in 23 patients with acute myocardial infarction (AMI), 10 with pulmonary embolism (PE), and 10 with deep vein thrombosis (DVT). At the onset of AMI, plasma levels of tissue-type plasminogen activator (t-PA), PA inhibitor-I (PAI-I), fibrin-D-dimer, thrombin-antithrombin complex (TAT), and plasmin-plasmin inhibitor complex (PPIC) were significantly increased. Both the plasma total TFPI and free-TFPI levels in the AMI patients were significantly higher than those in the healthy volunteers, PE patients, and DVT patients. There was no significant difference in total TFPI or free-TFPI among patients with PE, those with DVT, and healthy volunteers. One hour after percutaneous transluminal coronary angioplasty (PTCA) in the AMI group, the total TFPI level was further increased, and it was significantly reduced 24 hr after PTCA, to a level similar to that in healthy volunteers. Free-TFPI showed a pattern similar to that of total TFPI. The ratio of free-TFPI/total TFPI was highest 1 hr after PTCA. Increased TFPI in AMI patients might be released from ischemic tissues.
Authors:
Y Kamikura; H Wada; A Yamada; M Shimura; K Hiyoyama; H Shiku; M Tanigawa; H Nishikawa; N Yamada; N Isaka; T Nakano; K Kumeda; H Kato
Related Documents :
15194027 - Comparison of frequency of left ventricular thrombi in patients with anterior wall vers...
19857407 - Lack of association between left bundle-branch block and acute myocardial infarction in...
20922537 - Effects of telmisartan on markers of ventricular remodeling in patients with acute myoc...
19652617 - Achievement of secondary preventive goals after acute myocardial infarction: a comparis...
1677537 - Role of granulocytes and c5a in myocardial response to zymosan-activated serum.
6415827 - Diagnosis and management of myocardial ischemia in the postoperative period.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of hematology     Volume:  55     ISSN:  0361-8609     ISO Abbreviation:  Am. J. Hematol.     Publication Date:  1997 Aug 
Date Detail:
Created Date:  1997-09-03     Completed Date:  1997-09-03     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  7610369     Medline TA:  Am J Hematol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  183-7     Citation Subset:  IM    
Affiliation:
Second Department of Internal Medicine, Mie University School of Medicine, Tsu-city, Mie-ken, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Angioplasty, Transluminal, Percutaneous Coronary
Antifibrinolytic Agents / analysis,  blood
Antithrombin III / analysis
Female
Fibrin Fibrinogen Degradation Products / analysis
Fibrinolysin / analysis
Humans
Lipoproteins / blood*
Male
Middle Aged
Myocardial Infarction / blood*
Peptide Hydrolases / analysis
Plasminogen Activator Inhibitor 1 / blood
Pulmonary Embolism / blood
Thrombosis / blood
Tissue Plasminogen Activator / blood
alpha-2-Antiplasmin*
Chemical
Reg. No./Substance:
0/Antifibrinolytic Agents; 0/Fibrin Fibrinogen Degradation Products; 0/Lipoproteins; 0/Plasminogen Activator Inhibitor 1; 0/alpha-2-Antiplasmin; 0/antithrombin III-protease complex; 0/fibrin fragment D; 0/lipoprotein-associated coagulation inhibitor; 0/plasmin-plasmin inhibitor complex; 9000-94-6/Antithrombin III; EC 3.4.-/Peptide Hydrolases; EC 3.4.21.68/Tissue Plasminogen Activator; EC 3.4.21.7/Fibrinolysin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Morphological variants of leukemic cells in B chronic lymphocytic leukemia are associated with diffe...
Next Document:  Cancer incidence rate and mortality rate in sickle cell disease patients at Howard University Hospit...